tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences Balance Sheet

Annexon Biosciences Balance Sheet

Annexon Biosciences's total assets for Q1 2022 were $250.57M, a decrease of -12.71% from the previous quarter. ANNX total liabilities were $49.95M for the fiscal quarter, a -9.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 287.04M$ 355.95M$ 49.90M$ 48.15M
Total Liabilities
$ 55.13M$ 11.67M$ 6.37M$ 10.27M
Total Equity Gross Minority
$ 231.91M$ 344.28M$ 43.53M$ 37.88M
Total Capitalization
$ 231.91M$ 344.28M$ 43.53M$ 37.88M
Preferred Stock Equity
--$ 143.98M$ 102.08M
Capital Lease Obligations
$ 34.59M$ 0.00--
Currency in USD

Annexon Biosciences Debt to Assets


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis